直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 110922
タイトル別表記
尿毒素物質インドキシル硫酸はヘプシジン制御を介して慢性腎臓病における鉄代謝を障害する
Effect of indoxyl sulfate on hepcidin regulation
著者
濱野, 裕章 徳島大学大学院医科学教育部(医学専攻) 徳島大学 教育研究者総覧 KAKEN研究者をさがす
Watanabe, Hiroaki Tokushima University
堀ノ内, 裕也 Tokushima University
武智, 研志 Tokushima University
キーワード
Indoxyl sulfate
chronic kidney disease
CKD
hepcidin
iron
anemia
資料タイプ
学位論文
抄録
Background: Hepcidin secreted by hepatocytes is a key regulator of iron metabolism throughout the body. Hepcidin concentrations are increased in chronic kidney disease (CKD), contributing to abnormalities in iron metabolism. Levels of indoxyl sulfate (IS), a uremic toxin, are also elevated in CKD. However, the effect of IS accumulation on iron metabolism remains unclear.
Methods: We used HepG2 cells to determine the mechanism by which IS regulates hepcidin concentrations. We also used a mouse model of adenine-induced CKD. The CKD mice were divided into two groups: one was treated using AST-120 and the other received no treatment. We examined control mice, CKD mice, CKD mice treated using AST-120, and mice treated with IS via drinking water.
Results: In the in vitro experiments using HepG2 cells, IS increased hepcidin expression in a dose-dependent manner. Silencing of the aryl hydrocarbon receptor (AhR) inhibited IS-induced hepcidin expression. Furthermore, IS induced oxidative stress, and antioxidant drugs diminished IS-induced hepcidin expression. Adenine-induced CKD mice demonstrated an increase in hepcidin concentrations; this increase was reduced by AST-120, an oral adsorbent of the uremic toxin. CKD mice showed renal anemia, decreased plasma iron concentration, increased plasma ferritin, and increased iron content in the spleen. Ferroportin was decreased in the duodenum and increased in the spleen. These changes were ameliorated by AST-120 treatment. Mice treated by direct IS administration showed hepatic hepcidin upregulation.
Conclusion: IS affects iron metabolism in CKD by participating in hepcidin regulation via pathways that depend on AhR and oxidative stress.
掲載誌名
Nephrology Dialysis Transplantation
ISSN
09310509
14602385
cat書誌ID
AA1073277X
AA12096159
出版者
Oxford University Press
33
4
開始ページ
586
終了ページ
597
発行日
2017-08-23
備考
内容要旨・審査要旨・論文本文の公開
本論文は,著者Hirofumi Hamanoの学位論文として提出され,学位審査・授与の対象となっている。
This is a pre-copyedited, author-produced version of an article accepted for publication in Nephrology Dialysis Transplantation following peer review. The version of record, Nephrology Dialysis Transplantation (2017) Article ID: gfx252 is available online at: https://doi.org/10.1093/ndt/gfx252.
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
博士論文全文を含む
文科省報告番号
甲第3101号
学位記番号
甲医第1345号
学位授与年月日
2017-09-28
学位名
博士(医学)
学位授与機関
徳島大学
部局
医学系
病院
薬学系